The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease.
Open accessAbstract
Organ-specific autoimmune diseases such as oophoritis, gastritis, thyroiditis, and orchitis were induced in female or male nude (nu/nu) mice by the transfer of nu/+spleen cells from which particular Lyt T cell subset(s) had been removed: nu/+spleen cells treated with anti-Lyt-1 plus complement (C) caused disease in recipient nude mice; anti-Lyt-2 plus C-treated spleen cells, in contrast, did not. The cells responsible for disease induction are believed to be Thy-1+, Lyt-1-, 2,3- (Thy-1, Lyt-1, 2,3), since spleen cells treated with mixed antisera, including anti-Lyt-1 and anti-Lyt-2, plus C, could induce the disease with almost the same incidence as anti-Lyt-1 plus C-treated cells (oophoritis 50%, gastritis 25%, thyroiditis 10-20%, and orchitis 40%). Cells treated with mixed antisera of anti-Thy-1, anti-Lyt-1, and anti-Lyt-2, plus C, could not induce autoimmune disease. Each induced autoimmune disease could be adoptively transferred to other nude mice via spleen cells, with resulting histological lesion of corresponding organs and development of specific circulating autoantibodies. Since anti-Thy-1 plus C treatment of donor spleen cells abrogated the capacity to transfer the disease, we conclude that T cells are required as effector cells, and that these may develop from Lyt-1-, 2,3- cells. Lyt-1+, 2,3- cells were demonstrated to have suppressive activity upon the development of the diseases; induction of autoimmunity was completely inhibited by the cotransfer of Lyt-1+, 2,3- cells with Lyt-1-, 2,3- cells. When anti-Lyt-2 plus C-treated cells (i.e., Lyt-1+, 2,3- and Lyt-1-, 2,3- cells) were mixed with anti-Lyt-1 and anti-Lyt-2 plus C-treated cells (i.e., Lyt-1-, 2,3- cells) in various ratios, then transferred to nude mice, the development of each autoimmune disease was clearly inhibited, even by small doses of Lyt-1+, 2,3- cells. The autoimmune disease we were able to induce was quite similar to human organ-specific autoimmune disease in terms of the spectrum of organs involved, histopathological features, and the development of autoantibodies to corresponding organ components (oocytes, parietal cells, thyroid colloid, including thyroglobulin, and sperm).(ABSTRACT TRUNCATED AT 400 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The clonal selection theory of acquired immunity
Burnet, F. M. (1959) · Vanderbilt University Press eBooks · doi:10.5962/bhl.title.8281 · Cited by 2,619
Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens*
Ledbetter, J. A., & HERZENBERG, L. A. (1979) · Immunological Reviews · doi:10.1111/j.1600-065x.1979.tb00289.x · Cited by 1,914
Bretscher, P., & Cohn, M. (1970) · Science · doi:10.1126/science.169.3950.1042 · Cited by 1,692
Andrews, B. S., Eisenberg, R. A., Theofilopoulos, A. N., Izui, S., Wilson, C. B., McConahey, P. J., Murphy, E. D., Roths, J. B., & Dixon, F. J. (1978) · The Journal of experimental medicine · doi:10.1084/jem.148.5.1198 · Cited by 1,598
Ledbetter, J. A., Rouse, R. V., Micklem, H. S., & Herzenberg, L. A. (1980) · The Journal of Experimental Medicine · doi:10.1084/jem.152.2.280 · Cited by 613
T Cell Control of Antibody Production
Gershon, R. K. (1974) · Springer eBooks · doi:10.1007/978-1-4684-3045-5_1 · Cited by 575
Sakaguchi, S., Takahashi, T., & Nishizuka, Y. (1982) · The Journal of experimental medicine · doi:10.1084/jem.156.6.1577 · Cited by 342
Self-citationEvidence for the clonal abortion theory of B-lymphocyte tolerance.
Nossal, G. J., & Pike, B. L. (1975) · The Journal of experimental medicine · doi:10.1084/jem.141.4.904 · Cited by 295
Gleichmann, E., Elven, E. H. V., & van der Veen, J. P. W. (1982) · European Journal of Immunology · doi:10.1002/eji.1830120210 · Cited by 269
Genetic susceptibility to post-thymectomy autoimmune diseases in mice
Kojima, A., & Prehn, R. T. (1981) · Immunogenetics · doi:10.1007/bf00344296 · Cited by 262
Cited by
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325
Self-citationSakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
Self-citationSakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
Self-citationThornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
FOXP3+ regulatory T cells in the human immune system
Sakaguchi, S., Miyara, M., Costantino, C. M., & Hafler, D. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2785 · Cited by 2,439
Self-citationTakahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.303 · Cited by 2,233
“, thyroiditis, gastritis, and insulin-dependent diabetes mellitus) in otherwise normal rodents, and reconstitution of the removed population prevents the autoimmune development (12, 13).”
BackgroundMethodSelf-citationRead, S., Malmström, V., & Powrie, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.295 · Cited by 2,205
CD4+CD25high Regulatory Cells in Human Peripheral Blood
Baecher-Allan, C., Brown, J. A., Freeman, G. J., & Hafler, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1245 · Cited by 1,859
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
Sakaguchi, S. (2000) · Cell · doi:10.1016/s0092-8674(00)80856-9 · Cited by 1,815
Self-citationStimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance
Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y., & Sakaguchi, S. (2002) · Nature Immunology · doi:10.1038/ni759 · Cited by 1,729
Self-citationTakahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J., & Sakaguchi, S. (1998) · International Immunology · doi:10.1093/intimm/10.12.1969 · Cited by 1,568
Self-citationShimizu, J., Yamazaki, S., & Sakaguchi, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5211 · Cited by 1,491
Self-citationAutoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.387 · Cited by 1,330
Self-citationRegulatory T Cells in Autoimmmunity
Shevach, E. M. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.423 · Cited by 1,236
Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific
Thornton, A. M., & Shevach, E. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.183 · Cited by 1,229
Itoh, M., Takahashi, T., Sakaguchi, N., Kuniyasu, Y., Shimizu, J., Otsuka, F., & Sakaguchi, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5317 · Cited by 1,211
Self-citationMultiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
Powrie, F., Carlino, J., Leach, M. W., Mauze, S., & Coffman, R. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2669 · Cited by 894
Suri-Payer, E., Amar, A. Z., Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1212 · Cited by 860
Rudensky, A. Y. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01018.x · Cited by 765
Betterle, C., Dal Pra, C., Mantero, F., & Zanchetta, R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0466 · Cited by 758
Regulatory T cells in autoimmune disease
Dominguez-Villar, M., & Hafler, D. A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0120-4 · Cited by 713
CD40/CD154 Interactions at the Interface of Tolerance and Immunity
Quezada, S. A., Jarvinen, L. Z., Lind, E. F., & Noelle, R. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104533 · Cited by 683
HUMAN T CELL RESPONSES AGAINST MELANOMA
Boon, T., Coulie, P. G., Eynde, B. J. V. D., & Bruggen, P. V. D. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090733 · Cited by 651
Multiple immuno-regulatory defects in type-1 diabetes
Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin‐Su, K., Ten, S., Sanz, M. M., Exley, M. A., Wilson, B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13605 · Cited by 640
Gregori, S., Casorati, M., Amuchastegui, S., Smiroldo, S., Davalli, A. M., & Adorini, L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1945 · Cited by 617
Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter
Wan, Y. Y., & Flavell, R. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501701102 · Cited by 576
Mother's little helpers: mechanisms of maternal-fetal tolerance
Trowsdale, J., & Betz, A. G. (2006) · Nature Immunology · doi:10.1038/ni1317 · Cited by 575
Coutinho, A., Kazatchkine, M. D., & Avrameas, S. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80053-0 · Cited by 573
Multiple immuno-regulatory defects in type-1 diabetes
Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin-Su, K., Ten, S., Sanz, M., Exley, M., Wilson, B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213605 · Cited by 566
Yamagiwa, S., Gray, J. D., Hashimoto, S., & Horwitz, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7282 · Cited by 538
Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance
Nedjic, J., Aichinger, M., Emmerich, J., Mizushima, N., & Klein, L. (2008) · Nature · doi:10.1038/nature07208 · Cited by 532
Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State
Fisson, S., Darrasse-Jèze, G., Litvinova, E., Septier, F., Klatzmann, D., Liblau, R., & Salomon, B. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030686 · Cited by 522
T cell receptor signalling in the control of regulatory T cell differentiation and function
Li, M. O., & Rudensky, A. Y. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.26 · Cited by 493
“Nature Reviews | Immunology PtdIns(4,5)P2”
InfluentialAssociation between parasite infection and immune responses in multiple sclerosis
Correale, J., & Farez, M. (2007) · Annals of Neurology · doi:10.1002/ana.21067 · Cited by 467
T cell responses: naïve to memory and everything in between
Pennock, N. D., White, J. T., Cross, E. W., Cheney, E. E., Tamburini, B. A., & Kedl, R. M. (2013) · Advances in Physiology Education · doi:10.1152/advan.00066.2013 · Cited by 461
Fehérvari, Z., & Sakaguchi, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423395 · Cited by 452
Self-citationActivation of CD25+CD4+ Regulatory T Cells by Oral Antigen Administration
Zhang, X., Izikson, L., Liu, L., & Weiner, H. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4245 · Cited by 445
Cao, D., Malmström, V., Baecher‐Allan, C., Hafler, D., Klareskog, L., & Trollmo, C. (2003) · European Journal of Immunology · doi:10.1002/immu.200390024 · Cited by 439
Yu, P., Lee, Y., Liu, W., Krausz, T., Chong, A., Schreiber, H., & Fu, Y.-X. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041684 · Cited by 432
Developmental regulation of Foxp3 expression during ontogeny
Fontenot, J. D., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050784 · Cited by 417
Immunoregulation in the tissues by γδ T cells
Hayday, A., & Tigelaar, R. (2003) · Nature Reviews Immunology · doi:10.1038/nri1030 · Cited by 414
BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis
Roychoudhuri, R., Hirahara, K., Mousavi, K., Clever, D., Klebanoff, C. A., Bonelli, M., Sciumè, G., Zare, H., Vahedi, G., Dema, B., et al. (2013) · Nature · doi:10.1038/nature12199 · Cited by 407
Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease
Longhi, M. S., Ma, Y., Bogdanos, D. P., Cheeseman, P., Mieli-Vergani, G., & Vergani, D. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.03.008 · Cited by 405
Treg Heterogeneity, Function, and Homeostasis
Shevyrev, D., & Tereshchenko, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03100 · Cited by 404
Molecular Mechanisms Underlying FOXP3 Induction in Human T Cells
Mantel, P.-Y., Ouaked, N., Rückert, B., Karagiannidis, C., Welz, R., Blaser, K., & Schmidt-Weber, C. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3593 · Cited by 399
Ohta, A., Kini, R., Ohta, A., Subramanian, M., Madasu, M., & Sitkovsky, M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00190 · Cited by 398
Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells
Mahnke, K., Qian, Y., Knop, J., & Enk, A. H. (2003) · Blood · doi:10.1182/blood-2002-10-3229 · Cited by 388
Regulatory T cells – a brief history and perspective
Sakaguchi, S., Wing, K., & Miyara, M. (2007) · European Journal of Immunology · doi:10.1002/eji.200737593 · Cited by 362
Self-citationBoth CD4+CD25+ and CD4+CD25− Regulatory Cells Mediate Dominant Transplantation Tolerance
Graca, L., Thompson, S., Lin, C.-Y., Adams, E., Cobbold, S. P., & Waldmann, H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5558 · Cited by 362
Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?
Muranski, P., Boni, A., Wrzesinski, C., Citrin, D. E., Rosenberg, S. A., Childs, R., & Restifo, N. P. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0666 · Cited by 358
Immune and Inflammatory Role in Renal Disease
Imig, J. D., & Ryan, M. J. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120028 · Cited by 356
Intricacies of TGF-β signaling in Treg and Th17 cell biology
Wang, J., Zhao, X., & Wan, Y. Y. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-01036-7 · Cited by 356
Human FoxP3+ regulatory T cells in systemic autoimmune diseases
Miyara, M., Gorochov, G., Ehrenstein, M., Musset, L., Sakaguchi, S., & Amoura, Z. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.004 · Cited by 342
Self-citationTumor-infiltrating T lymphocytes: Friends or foes?
Yu, P., & Fu, Y.-X. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700389 · Cited by 299
“Adoptive transfer of CDp CD2p T cells could prevent the development of organ-specific autoimmunity”
BackgroundJenq, R. R., & van den Brink, M. R. M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2804 · Cited by 299
Mauro, F. R., Foa, R., Cerretti, R., Giannarelli, D., Coluzzi, S., Mandelli, F., & Girelli, G. (2000) · Blood · doi:10.1182/blood.v95.9.2786.009k30_2786_2792 · Cited by 295
Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease
Okazaki, K., Uchida, K., Koyabu, M., Miyoshi, H., & Takaoka, M. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0386-x · Cited by 292
Kuniyasu, Y., Takahashi, T., Itoh, M., Shimizu, J., Toda, G., & Sakaguchi, S. (2000) · International Immunology · doi:10.1093/intimm/12.8.1145 · Cited by 290
Self-citationViral Trigger for Type 1 Diabetes
Filippi, C. M., & von Herrath, M. G. (2008) · Diabetes · doi:10.2337/db07-1023 · Cited by 285
Control of Autoimmunity by Naturally Arising Regulatory CD4+ T Cells
(2003) · Advances in Immunology · doi:10.1016/s0065-2776(03)81008-8 · Cited by 283
Immunity to the respiratory pathogen Bordetella pertussis
Higgs, R., Higgins, S. C., Ross, P. J., & Mills, K. H. G. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.54 · Cited by 283
Emerging Functions of Regulatory T Cells in Tissue Homeostasis
Sharma, A., & Rudra, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00883 · Cited by 262
Hafler, D. A., Slavik, J. M., Anderson, D. E., O'Connor, K. C., De Jager, P., & Baecher‐Allan, C. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00240.x · Cited by 260
Beers, D. R., Zhao, W., Wang, J., Zhang, X., Wen, S., Neal, D., Thonhoff, J. R., Alsuliman, A. S., Shpall, E. J., Rezvani, K., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89530 · Cited by 254
Regulation of Immune Responses by T Cells
Jiang, H., & Chess, L. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055446 · Cited by 253
Immune Responses to Lentiviral Vectors
Follenzi, A., Santambrogio, L., & Annoni, A. (2007) · Current Gene Therapy · doi:10.2174/156652307782151515 · Cited by 87
Exendin‐4 Therapy in NOD Mice with New‐Onset Diabetes Increases Regulatory T Cell Frequency
Xue, S., Wasserfall, C. H., Parker, M., Brusko, T. M., McGrail, S., McGrail, K., Moore, M., Campbell‐Thompson, M., Schatz, D. A., Atkinson, M. A., et al. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1447.049 · Cited by 51
Metadata
- Authors
- Sakaguchi, S., Fukuma, K., Kuribayashi, K., & Masuda, T.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1985-01-01
- Volume
- 161
- Issue
- 1
- Pages
- 72-87
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2080890675
- Cited by
- 729
- References
- 24
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.